Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7269 p448-449
4 October 2003

This page
Reprint
Photocopy

   

PDF* 90K

Letters

  Prescription charges
  Community pharmacy
  Medical research
  Remuneration
  Advertising
  Primary care
  Fluoridation
  The Society


Letters to the Editor

Primary care

Primary care pharmacists are not leaving the profession

From Dr B. P. Curwain, MRPharmS

The reported comments made by Royal Pharmaceutical Society Council member Wally Dove and Professor Liz Kay at the British Pharmaceutical Conference (PJ, 27 September, p414) serve only to show how misinformed and out of date some senior pharmacists can be about the work done by primary care pharmacists. If you were to tell any member of the New Forest Primary Care Trust’s medicines management team that they are “part-time accountants” who are “doing little to improve the quality of prescribing”, you would receive a most robust although, of course, courteous reply.

We constantly strive to improve both the process and practice of prescribing, have fought with the accountancy-minded factions of the National Health Service to get proper funding for the drugs our patients need and have, in my PCT, removed budgetary performance from the prescribing incentive scheme in favour of quality indicators. In the current year we have increased funding for GP prescribing by 19 per cent. My PCT does not have a formulary.

We spend as little time as possible in our offices and as much as we can out with doctors, pharmacists, nurses and others, including, in my case, patients. In many PCTs the pharmacy team are the only clinicians among the paid headquarters staff. As such, we are able to provide an effective and sympathetic link between NHS managers and the clinicians who deliver the services. We do encourage the use of new drugs when appropriate but are increasingly mindful of the evidence base for such decisions. Nobody likes to see public money wasted and we try to maximise the effectiveness, first in terms of therapeutics and second in terms of cost, of the medicines that are used. Pharmacists have been spectacularly successful since the mid 1990s at containing rising costs but the main easy changes have, mostly, already been made and prescribing is now quality-driven via national service frameworks and National Institute for Clinical Excellence guidance.

It is depressing to see how little the Society seems to know about what we do, including struggling to develop community pharmacy services. Many of my primary care colleagues believe Lambeth to be largely irrelevant to them, which it is not, but their view is understandable.

Brian Curwain
Chief Pharmacist and Head of Primary Care
New Forest PCT

Send your letter to The Editor

Previous Topic (Advertising)
Next Topic (Fluoridation)

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal